Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients
- 18 November 2010
- journal article
- clinical trial
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 27 (1) , 45-53
Abstract
(2011). Omalizumab in the management of oral corticosteroid-dependent IGE-mediated asthma patients. Current Medical Research and Opinion: Vol. 27, No. 1, pp. 45-53. doi: 10.1185/03007995.2010.536208Keywords
This publication has 13 references indexed in Scilit:
- Omalizumab in patients with severe persistent allergic asthma in a real-life setting in GermanyRespiratory Medicine, 2009
- Control del asma y de la calidad de vida en pacientes asmáticos alérgicos graves con tratamiento anti-IgE (omalizumab)Medicina Clinica, 2009
- Twelve years’ experience with methotrexate for GINA treatment step 5 asthma patientsCurrent Medical Research and Opinion, 2008
- Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label studyRespiratory Medicine, 2008
- American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxisJournal of Allergy and Clinical Immunology, 2007
- Home Therapy with Subcutaneous Anti-Immunoglobulin-E Antibody Omalizumab in 25 Patients with Immunoglobulin-E–Mediated (Allergic) AsthmaJournal of Asthma, 2007
- ISAAC international study of asthma and allergies in childhoodPediatric Pulmonology, 2006
- Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled studyRespiratory Medicine, 2006
- Efectividad y eficiencia de una consulta externa monográfica de asma corticodependienteArchivos de Bronconeumología, 2001
- Prevalencia de bronquitis crónica, asma y obstrucción al flujo aéreo en una zona urbano-industrial de CataluñaArchivos de Bronconeumología, 1999